Differentiated thyroid cancer patients who receive radioiodine (RAI) treatment after surgery have increased relative survival rates compared to those who do not receive the treatment. According to new ...

The rates of recurrence-free and disease-specific survival were comparable between patients with differentiated thyroid cancer with immunocompromised status and matched patients with immunocompetent ...

A Sarasota Memorial specialist helped create new guidelines for treating differentiated thyroid cancer. The "2025 American Thyroid Association Management Guidelines" are the first update since 2015.

There is no universally accepted definition for recurrence of differentiated thyroid cancer (DTC) across treatment categories such as total thyroidectomy with or without radioactive iodine ablation ...

Please provide your email address to receive an email when new articles are posted on . Of 155 young patients diagnosed with differentiated thyroid cancer, 52.3% had excellent response to treatment.

Postoperative radioiodine (RAI) versus no radiodine therapy for patients with low-risk differentiated thyroid cancer: A systematic review and meta-analysis. Survival outcomes in radioactive ...

The leading, peer-reviewed resource for original articles, patient-focused reports, and translational research on thyroid cancer and all thyroid related diseases. These revised guidelines begin with ...

Researchers from the Endocrine Tumors group at the Germans Trias i Pujol Research Institute (IGTP), in collaboration with five university hospitals, have conducted the first comprehensive study of DNA ...

Results of management of cervical lymph node metastases in differentiated thyroid carcinoma: Experience in an upper middle-income country. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...

Two prospective trials of immunotherapy in thyroid cancer, one of them negative, provided support for precision-medicine approaches that include immunotherapy. The studies were reported simultaneously ...